{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T12:45:16Z","timestamp":1786193116269,"version":"build-2736575974"},"posted":{"date-parts":[[2025,11,19]]},"group-title":"Neurology","reference-count":31,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministerstvo \u0161kolstv\u00ed, ml\u00e1d\u017ee a tlov\u00fdchovy, Prague, CZ","award":["LX22NPO5107"],"award-info":[{"award-number":["LX22NPO5107"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,8,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Within the amyloid\/tau\/neurodegeneration (ATN) framework, hippocampal (H) and inferior parietal lobule (IPL) atrophy are established markers of neurodegeneration (N+), whereas the biological significance of choroid plexus (ChP) enlargement remains uncertain. Although amyloid positivity (A+) underpins the current biological definition of Alzheimer\u2019s disease, the extent to which it is consistently associated with structural neurodegeneration remains unclear. We investigated the relationship between A+ and structural neurodegeneration using structural MRI, amyloid PET, and cognitive data from 872 participants from the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI). Regional brain volumes (H, IPL and ChP) were classified as abnormal using validated normative thresholds. Diagnostic performance was evaluated using multiple machine-learning approaches, and associations between structural phenotypes, cognitive profiles and cerebrospinal fluid (CSF) biomarkers were examined.<\/jats:p>\n                <jats:p>Among 872 participants, 411 were amyloid-negative healthy subjects, 339 had amyloid-positive mild cognitive impairment, and 122 had amyloid-positive Alzheimer\u2019s disease dementia. At the group level, H and IPL progressively decreased, whereas ChP volume increased across disease stages (all P&lt;0.001). However, 45% of amyloid-positive individuals exhibited no detectable structural neurodegeneration. Consistently, machine-learning models demonstrated limited individual-level diagnostic performance, with a maximum overall accuracy of 0.60 [0.57\u20130.62]. Hierarchical clustering identified four cognitive phenotypes that mapped onto distinct structural signatures.<\/jats:p>\n                <jats:p>Amyloid positivity alone does not uniformly predict structural neurodegeneration. The marked dissociation between amyloid pathology and MRI-defined neurodegeneration demonstrates substantial biological heterogeneity within amyloid-positive Alzheimer\u2019s disease and supports the concept of distinct structural amyloidopathies. These findings have important implications for biomarker interpretation, patient stratification, and the development of precision therapeutic strategies.<\/jats:p>","DOI":"10.1101\/2025.11.17.25340406","type":"posted-content","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T01:45:17Z","timestamp":1763603117000},"source":"Crossref","is-referenced-by-count":0,"title":["Structural heterogeneity reveals distinct amyloidopathies in Alzheimer\u2019s disease"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5074-8971","authenticated-orcid":false,"given":"Jan Sebastian","family":"Novotn\u00fd","sequence":"first","affiliation":[{"name":"Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic"},{"name":"Department of Psychology and Abnormal Psychology, Faculty of Education, Palacky University Olomouc, Olomouc, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9809-3609","authenticated-orcid":false,"given":"M\u00e1ria","family":"\u010carn\u00e1","sequence":"additional","affiliation":[{"name":"Central European Institute of Technology, Masaryk University, Brno, Czech Republic"},{"name":"International Translational Neuroscience Research Institute, School of Pharmacological Science, School of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Lyburn","sequence":"additional","affiliation":[{"name":"Departments of Radiology, Gloucestershire Hospitals NHS Foundation Trust, Gloucester, United Kingdom"},{"name":"Cobalt Medical Charity, Cheltenham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun","family":"Kuruvilla","sequence":"additional","affiliation":[{"name":"The Fritchie Centre, Gloucestershire Health and Care NHS Foundation Trust, Cheltenham, United Kingdom"},{"name":"School of Health & Social Care, University of Gloucestershire, Cheltenham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8430-8755","authenticated-orcid":false,"given":"Gorazd Bernard","family":"Stokin","sequence":"additional","affiliation":[{"name":"Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic"},{"name":"School of Health & Social Care, University of Gloucestershire, Cheltenham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026080804550513000_2025.11.17.25340406v2.1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(91)90609-V"},{"key":"2026080804550513000_2025.11.17.25340406v2.2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1566067"},{"key":"2026080804550513000_2025.11.17.25340406v2.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.02.018"},{"issue":"4","key":"2026080804550513000_2025.11.17.25340406v2.4","doi-asserted-by":"crossref","first-page":"414","DOI":"10.14283\/jpad.2021.56","article-title":"Donanemab (LY3002813) Phase 1b Study in Alzheimer\u2019s Disease: Rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 Imaging","volume":"8","year":"2021","journal-title":"J Prev Alzheimers Dis"},{"key":"2026080804550513000_2025.11.17.25340406v2.5","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-021-00813-8"},{"issue":"3","key":"2026080804550513000_2025.11.17.25340406v2.6","first-page":"211","article-title":"A critical analysis of the \u2018amyloid cascade hypothesis\u2019","volume":"52","year":"2014","journal-title":"Folia Neuropathol"},{"issue":"11","key":"2026080804550513000_2025.11.17.25340406v2.7","doi-asserted-by":"crossref","first-page":"e213675","DOI":"10.1212\/WNL.0000000000213675","article-title":"Validating the Amyloid Cascade Through the Revised Criteria of Alzheimer\u2019s Association Workgroup 2024 for Alzheimer Disease","volume":"104","year":"2025","journal-title":"Neurology"},{"key":"2026080804550513000_2025.11.17.25340406v2.8","first-page":"135","article-title":"Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer\u2019s disease","volume":"2","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"2026080804550513000_2025.11.17.25340406v2.9","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70783"},{"key":"2026080804550513000_2025.11.17.25340406v2.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.008"},{"key":"2026080804550513000_2025.11.17.25340406v2.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.005"},{"key":"2026080804550513000_2025.11.17.25340406v2.12","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-011-2205-4"},{"key":"2026080804550513000_2025.11.17.25340406v2.13","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.55.10.967"},{"key":"2026080804550513000_2025.11.17.25340406v2.14","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.3.631"},{"key":"2026080804550513000_2025.11.17.25340406v2.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-0618(01)00096-5"},{"key":"2026080804550513000_2025.11.17.25340406v2.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2020.01.005"},{"key":"2026080804550513000_2025.11.17.25340406v2.17","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12970"},{"key":"2026080804550513000_2025.11.17.25340406v2.18","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-023-10572-9"},{"key":"2026080804550513000_2025.11.17.25340406v2.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2025.08.003"},{"key":"2026080804550513000_2025.11.17.25340406v2.20","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-024-00603-y"},{"key":"2026080804550513000_2025.11.17.25340406v2.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2012.02.084"},{"key":"2026080804550513000_2025.11.17.25340406v2.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(02)00569-X"},{"key":"2026080804550513000_2025.11.17.25340406v2.23","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.60.7.989"},{"key":"2026080804550513000_2025.11.17.25340406v2.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2008.01.010"},{"issue":"2","key":"2026080804550513000_2025.11.17.25340406v2.25","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/alz.12668","article-title":"Quantification of amyloid beta and tau PET without a structural MRI","volume":"19","year":"2023","journal-title":"Alzheimers Dement"},{"key":"2026080804550513000_2025.11.17.25340406v2.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2015.05.001"},{"key":"2026080804550513000_2025.11.17.25340406v2.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2014.07.003"},{"key":"2026080804550513000_2025.11.17.25340406v2.28","doi-asserted-by":"crossref","first-page":"656808","DOI":"10.3389\/fnins.2021.656808","article-title":"Norms for Automatic Estimation of Hippocampal Atrophy and a Step Forward for Applicability to the Italian Population","volume":"15","year":"2021","journal-title":"Front Neurosci"},{"key":"2026080804550513000_2025.11.17.25340406v2.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2017.01.014"},{"key":"2026080804550513000_2025.11.17.25340406v2.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2015.09.009"},{"issue":"10","key":"2026080804550513000_2025.11.17.25340406v2.31","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1038\/s41591-024-03144-x","article-title":"Brain aging patterns in a large and diverse cohort of 49,482 individuals","volume":"30","year":"2024","journal-title":"Nat Med"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.11.17.25340406","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T11:55:15Z","timestamp":1786190115000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2025.11.17.25340406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":31,"URL":"https:\/\/doi.org\/10.1101\/2025.11.17.25340406","relation":{},"subject":[],"published":{"date-parts":[[2025,11,19]]},"subtype":"preprint"}}